Advertisement
Video case report|Articles in Press

EUS diagnosis of hepatic angiomyolipoma

Open AccessPublished:March 01, 2023DOI:https://doi.org/10.1016/j.vgie.2022.12.013

      Video

      (mp4, (87.8 MB)

      FNA of a mass identified in the caudate lobe of the liver with US gastrovideoscope.

      Abbreviation:

      HAML (hepatic angiomyolipoma)

      Introduction

      Hepatic angiomyolipomas (HAMLs) are rare mesenchymal tumors consisting of blood vessels, smooth muscle cells, and fat cells.
      • Klompenhouwer A.J.
      • Dwarkasing R.S.
      • Doukas M.
      • et al.
      Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.
      Because of different components, appearance is variable on imaging. In general, intratumoral fatty tissue facilitates diagnosis.
      • Klompenhouwer A.J.
      • Dwarkasing R.S.
      • Doukas M.
      • et al.
      Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.
      ,
      • Damaskos C.
      • Garmpis N.
      • Garmpi A.
      • et al.
      Angiomyolipoma of the liver: a rare benign tumor treated with a laparoscopic approach for the first time.
      An HAML poor in fat may be misdiagnosed and frequently confused with hepatocellular carcinoma, hepatocellular adenoma, and cholangiocarcinoma, among others.
      • Klompenhouwer A.J.
      • Dwarkasing R.S.
      • Doukas M.
      • et al.
      Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.
      ,
      • Damaskos C.
      • Garmpis N.
      • Garmpi A.
      • et al.
      Angiomyolipoma of the liver: a rare benign tumor treated with a laparoscopic approach for the first time.
      In contrast, with high fat content, it can resemble a lipoma.

      Case Presentation

      A 53-year-old man with an intellectual disability and Cowden syndrome presented with vomiting, abdominal distention, and lethargy. Laboratory tests revealed WBC 13.1 k/μL, lipase 2147 U/L, aspartate aminotransferase 110 U/L, alanine aminotransferase 159 U/L, alkaline phosphatase 137 U/L, and total bilirubin 2.5 mg/dL. A contrasted abdominal CT scan showed acute cholecystitis, a common bile duct measuring 9 mm with possible choledocholithiasis, and an interval increase of a previously documented hypodense lesion in the caudate lobe measuring 2.4 cm concerning for possible neoplasm (Fig. 1). An MRI or magnetic resonance cholangiopancreatography was not feasible because of the presence of a vagal nerve stimulator implant. Our patient had significant developmental delay and was not deemed a transplant candidate; however, the family requested a diagnostic work-up of the liver lesion. Laparoscopic cholecystectomy was performed and intraoperative cholangiogram was positive, so an ERCP/EUS was scheduled because the lesion was not easily accessible percutaneously.
      Figure thumbnail gr1
      Figure 1Lesion in caudate lobe of liver seen on a CT scan with contrast.
      Upon endoscopic examination, esophageal glycogen acanthosis and gastric polyposis were noted (Figs. 2 and 3). Transduodenal EUS views revealed evidence of choledocholithiasis with dilated common bile duct. On transgastric views, a round, hyperechoic, homogeneous, solid lesion with well-defined borders measuring 2.3 × 2 cm was appreciated in the caudate lobe of the liver (Video 1, available online at www.giejournal.org). Color Doppler confirmed lack of significant vascular structures. Two passes were made with the 22-gauge needle using the slow-pull technique. Cytological rapid on-site evaluation was available and specimen adequacy was confirmed. Subsequently, an ERCP with sphincterotomy and balloon extraction of bile duct stones was performed.
      Figure thumbnail gr2
      Figure 2Esophageal glycogen acanthosis seen on EGD.
      Figure thumbnail gr3
      Figure 3Gastric polyposis observed during EGD.
      Pathologic diagnosis was consistent with hamartomatous growth in the liver analogous to angiomyolipoma (Figure 4, Figure 5, Figure 6).
      Figure thumbnail gr4
      Figure 4Angiomyolipoma seen on EUS. Long arrow shows the lesion, small arrow points to the middle hepatic vein, and arrowhead shows the inferior vena cava.
      Figure thumbnail gr5
      Figure 5FNA liver lesion showing angiomyolipoma.
      Figure thumbnail gr6
      Figure 6Specimen from FNA biopsy showing angiomyolipoma of the liver under high power arrowhead points to adipocytes.

      Discussion

      Ultrasound evaluation of HAMLs can reveal hyperechoic lesions when lipomatous and myomatous tissues predominate, or hypoechoic lesions when there is more angiomatous tissue.
      • Kamimura K.
      • Nomoto M.
      • Aoyagi Y.
      Hepatic angiomyolipoma: diagnostic findings and management.
      Punctiform or filiform vascular distribution can be seen on color Doppler with predominantly angiomatous lesions.
      • Kamimura K.
      • Nomoto M.
      • Aoyagi Y.
      Hepatic angiomyolipoma: diagnostic findings and management.
      On the CT and MRI scans, these lesions can be homogeneous or heterogeneous.
      • Klompenhouwer A.J.
      • Dwarkasing R.S.
      • Doukas M.
      • et al.
      Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.
      ,
      • Kamimura K.
      • Nomoto M.
      • Aoyagi Y.
      Hepatic angiomyolipoma: diagnostic findings and management.
      Use of contrast usually reveals a hyper-enhancing pattern in the arterial phase with prolonged enhancement in the venous phase. With EUS, benign liver lesions are usually hyperechogenic, not round or oval shaped. Malignant lesions are usually heterogeneous, have postacoustic enhancement, are hypoechogenic, are greater than 1 cm, and have distortion of adjacent structures (See Table 1).
      • Shuja A.
      • Alkhasawneh A.
      • Fialho A.
      • et al.
      Comparison of EUS-guided versus percutaneous and transjugular approaches for the performance of liver biopsies.
      Table 1Focal liver lesions and their appearance on EUS
      Focal liver lesionEUS features
      CystAnechoic; septa +/–; Doppler negative
      HemangiomaHypoechoic; homogeneous; Doppler positive
      Focal fatHyperechoic; homogeneous
      Focal nodular hyperplasiaHypo- or isoechoic; central hyperechoic signal +/–; stellate Doppler signal +/–
      AdenomaHeterogeneous; hypoechoic or hyperechoic
      Hepatocellular carcinomaHeterogeneous hypoechoic lesion with peripheral halo
      MetastasesHeterogenous; hypoechoic (usually); distortion of vasculature
      Cowden syndrome is one of the hereditary multisystem syndromes caused by mutations in the PTEN gene. Patients usually have benign overgrowths or hamartomas, but screening for cancers (colon, thyroid, breast, kidney, skin) is recommended.
      • Blumenthal G.M.
      • Dennis P.A.
      PTEN hamartoma tumor syndromes.
      The HAML lesion was likely related to PHTS (PTEN hamartoma tumor syndrome). There is at least 1 case report of multiorgan hamartomas, including the liver, in a patient with Cowden syndrome.
      • Lee E.J.
      • Jung W.S.
      • Ko J.M.
      • et al.
      Mutliorgan involvements of Cowden disease in a 50-year-old woman: a case report and literature overview.
      While there are no established guidelines for surveillance of HAMLs, our patient will have a CT scan every 2 years to monitor interval growth.
      Even though HAMLs are usually benign, they are often confused with other malignant tumors. EUS-guided biopsy is a useful method for diagnosis with results comparable with interventional radiology techniques and a good safety profile.
      • Shuja A.
      • Alkhasawneh A.
      • Fialho A.
      • et al.
      Comparison of EUS-guided versus percutaneous and transjugular approaches for the performance of liver biopsies.
      Successful histological diagnosis decreases morbidity and mortality and directs management decisions.
      There is scant EUS literature on the topic of HAML. Our article highlights the EUS findings of this rare condition and the advantage of EUS-guided tissue diagnosis in difficult-to-access lesions.

      Disclosure

      All authors disclosed no financial relationships.

      Supplementary data

      References

        • Klompenhouwer A.J.
        • Dwarkasing R.S.
        • Doukas M.
        • et al.
        Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.
        HPB (Oxford). 2020; 22: 622-629
        • Damaskos C.
        • Garmpis N.
        • Garmpi A.
        • et al.
        Angiomyolipoma of the liver: a rare benign tumor treated with a laparoscopic approach for the first time.
        In Vivo. 2017; 31: 1169-1173
        • Kamimura K.
        • Nomoto M.
        • Aoyagi Y.
        Hepatic angiomyolipoma: diagnostic findings and management.
        Int J Hepatol. 2012; 2012: 410781
        • Shuja A.
        • Alkhasawneh A.
        • Fialho A.
        • et al.
        Comparison of EUS-guided versus percutaneous and transjugular approaches for the performance of liver biopsies.
        Dig Liver Dis. 2019; 51: 826-830
        • Blumenthal G.M.
        • Dennis P.A.
        PTEN hamartoma tumor syndromes.
        Eur J Hum Genet. 2008; 16: 1289-1300
        • Lee E.J.
        • Jung W.S.
        • Ko J.M.
        • et al.
        Mutliorgan involvements of Cowden disease in a 50-year-old woman: a case report and literature overview.
        J Korean Soc Radiol. 2013; 69: 251-255